Robert Holloway, MD to Have Manuscript Published in the Oncologist

Choose the health content that's right for you, and get it delivered right in your inbox

Dr. Robert Holloway’s manuscript titled, “Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination With Carboplatin Versus Gemcitabine/Carboplatin for the Treatment of Platinum Sensitive Recurrent Ovarian Cancer: A Systematic Review,” has been accepted for publication by The Oncologist- The official journal of the Society for Translational Oncology. This manuscript was reviewed by Section Editors at The Oncologist and other external experts in the field.

Congratulations to Dr. Holloway for the scientific advancement that this manuscript represents.

Tuesday, October 25, 2011

Recent Blogs

A senior mother hugging her mature daughter
Blog
Breast Cancer Now Most Commonly Diagnosed Cancer Worldwide
A man drinking coffee while looking outside from his window
Blog
COVID-19 and Neurological Health: What We’ve Learned
Blog
How to Find the Neurological Care to Best Suit Your Needs
The Altamonte Springs team with patient, Ryan Nguyen,
Blog
A Patient Shares His Discectomy Experience at AdventHealth
Blog
After Late-Stage Cancer Diagnosis, Singer Sarah Harding Says COVID-19 is Not an Excuse to Delay Important Screening
View More Articles